Search research articles
Contact Us
Filters
Showing results (231-240 of 1,124) with videos related to
Page
of 113
Sort By:
Human Pathology
|
July 27, 2025
Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer
Qing Yin Wang, Nazim Benzerdjeb, Samuel Jaquet, et al.
Clinical Genitourinary Cancer
|
May 30, 2006
The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel
Fred Saad, Celestia S Higano, Oliver Sartor, et al.
The Canadian Journal of Urology
|
June 9, 2004
A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy
Robert Sabbagh, Michael McCormack, Francois Péloquin, et al.
The Canadian Journal of Urology
|
July 16, 2005
Early detection of prostate cancer with ultrasound-guided systematic needle biopsy
Pierre I Karakiewicz, Paul Perrotte, Mike McCormack, et al.
Molecular Cancer Research : MCR
|
January 30, 2007
Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer
Benjamin Péant, Jean-Simon Diallo, Laurent Lessard, et al.
Cancer Cell International
|
November 26, 2008
Ebp1 expression in benign and malignant prostate
Philippe O Gannon, Ismaël Hervé Koumakpayi, Cécile Le Page, et al.
The Prostate
|
May 18, 2006
An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines
Jean-Simon Diallo, Benjamin Péant, Laurent Lessard, et al.
European Urology
|
May 28, 2013
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
Benjamin A Gartrell, Robert E Coleman, Karim Fizazi, et al.
Cancer
|
May 7, 2008
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
Allan Lipton, Richard Cook, Fred Saad, et al.
Urology
|
August 11, 2004
uPM3, a new molecular urine test for the detection of prostate cancer
Yves Fradet, Fred Saad, Armen Aprikian, et al.
Page
of 113
Search research articles
Search
Showing results (231-240 of 1,124) with videos related to
Sort By:
Page
of 113
Human Pathology
|
July 27, 2025
Impact of hormone sensitivity status on aberrant expression of CK7, CK20, CDX2, GATA3 and TTF1 in prostate cancer
Qing Yin Wang, Nazim Benzerdjeb, Samuel Jaquet, et al.
Clinical Genitourinary Cancer
|
May 30, 2006
The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel
Fred Saad, Celestia S Higano, Oliver Sartor, et al.
The Canadian Journal of Urology
|
June 9, 2004
A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy
Robert Sabbagh, Michael McCormack, Francois Péloquin, et al.
The Canadian Journal of Urology
|
July 16, 2005
Early detection of prostate cancer with ultrasound-guided systematic needle biopsy
Pierre I Karakiewicz, Paul Perrotte, Mike McCormack, et al.
Molecular Cancer Research : MCR
|
January 30, 2007
Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer
Benjamin Péant, Jean-Simon Diallo, Laurent Lessard, et al.
Cancer Cell International
|
November 26, 2008
Ebp1 expression in benign and malignant prostate
Philippe O Gannon, Ismaël Hervé Koumakpayi, Cécile Le Page, et al.
The Prostate
|
May 18, 2006
An androgen-independent androgen receptor function protects from inositol hexakisphosphate toxicity in the PC3/PC3(AR) prostate cancer cell lines
Jean-Simon Diallo, Benjamin Péant, Laurent Lessard, et al.
European Urology
|
May 28, 2013
Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer
Benjamin A Gartrell, Robert E Coleman, Karim Fizazi, et al.
Cancer
|
May 7, 2008
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid
Allan Lipton, Richard Cook, Fred Saad, et al.
Urology
|
August 11, 2004
uPM3, a new molecular urine test for the detection of prostate cancer
Yves Fradet, Fred Saad, Armen Aprikian, et al.
Page
of 113